title: Should we use outpatient dobutamine or milrinone?
authors.affiliation: Department of Cardiovascular Medicine, National Cardiovascular Center, Osaka General Medical Center, Osaka, Japan. mkato@partners.org
authors.forename: Mahoto
authors.initials: M
authors.lastname: Kato
authors.forename: Shoji
authors.initials: S
authors.lastname: Sanada
authors.forename: Masafumi
authors.initials: M
authors.lastname: Kitakaze
mesh_terms: D002302:Cardiac Output / Q000187:drug effects; D002316:Cardiotonic Agents / Q000008:administration & dosage*; D004280:Dobutamine / Q000008:administration & dosage*; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D007275:Injections, Intravenous; D020105:Milrinone / Q000008:administration & dosage*; D010045:Outpatients; D016896:Treatment Outcome
chemical_list: D002316:Cardiotonic Agents; D004280:Dobutamine; D020105:Milrinone